SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Julius Caesar

PatientJulius Caesar
Date of birth1972-07-12
IdentifiersMRN HR-AC001-SYN; SSN (made up) 000-01-6022
Document date2026-08-18
AuthorLucius Fairbanks-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week follow-up after recurrent spells of collapse; test results and neurology consultation today. [S]

History of Present Illness

Julius Caesar returns two weeks after his first visit. He saw Dr. Lindqvist-Adeyemi of neurology this morning. He has had no further spell, though he woke once from a vivid, frightening dream, confused for a minute or two, which happens every few weeks. The EEG showed intermittent left temporal sharp waves. The MRI showed no new stroke but an old small infarct in the left posterior temporal lobe and moderate small-vessel white matter changes, with no tumor, vascular malformation, or cyst. CT angiography showed a small calcified plaque at the left carotid bifurcation, under 30 percent. The echocardiogram showed mild left ventricular thickening, no clot, and no shunt. The 14-day monitor showed sinus rhythm throughout; the one event he marked, light-headedness on standing up quickly, was in sinus rhythm. He has taken lisinopril every morning without cough or dizziness but did not keep the home blood pressure log. He has not driven, has showered rather than bathed, and has not ridden. He wants to know what the spells are and when he can drive again. [S]

ElementDetail
SpellsNone since the first visit; one confused awakening from a vivid dream
TestsEEG left temporal sharp waves; MRI chronic left temporal cortical infarct, no acute infarct; CTA carotid plaque under 30 percent; echo no source of embolism; 14-day monitor sinus rhythm
MedicinesLisinopril 10 mg daily; no cough or dizziness
Home blood pressureLog not kept
SafetyNot driving, swimming, or riding

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or weight loss
CardiovascularNegativeNo chest pain or palpitations; brief light-headedness on standing quickly
NeurologicalPositiveOne confused awakening from a vivid dream; no weakness, numbness, speech, or vision change; occasional mild headaches
PsychiatricNegativeImpatient but not low in mood

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Lisinopril 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth each morningOral route2026-08-04activeS
Levetiracetam 500 mg oral tablet, one tablet by mouth twice daily500 mg twice daily, morning and eveningOral route2026-08-18activeS
Atorvastatin 80 mg oral tablet, one tablet by mouth at bedtimeOne tablet by mouth at bedtimeOral route2026-08-18activeS
Aspirin 81 mg delayed-release tablet, one tablet by mouth dailyOne tablet by mouth daily with foodOral route2026-08-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-08-18Body height182cmS
2026-08-18Body weight75.8kgS
2026-08-18Body mass index (BMI) [Ratio]22.9kg/m2S
2026-08-18Systolic blood pressure140mm[Hg]S
2026-08-18Diastolic blood pressure88mm[Hg]S
2026-08-18Heart rate68/minS
2026-08-18Respiratory rate14/minS
2026-08-18Body temperature36.6CelS
2026-08-18Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-08-18Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-08-18Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
2026-08-18Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-08-18Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M86mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS

Physical Exam

Vital signs recorded on 2026-08-18; see the Vital Signs section. [S]

SystemFinding
GeneralWell; alert and composed
CardiovascularRegular rhythm; no carotid bruit; blood pressure 140/88 mmHg
NeurologicalNormal speech, naming, and repetition; visual fields full to confrontation; no pronator drift; normal strength, sensation, coordination, and gait
MouthTongue laceration healed

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent transient episodes of collapse: six days ago a witnessed collapse with stiffening and jerking of both arms for about a minute, a bitten tongue, and about twenty minutes of confusion, after a rising strange feeling and dizziness; two briefer spells of staring and unresponsiveness in the past eighteen months; cause not yet known (seizure, convulsive syncope, or transient ischemic attack)resolvedconfirmed R56.9S — Synthetic presenting problem anchored to the documented accounts of falling attacks and fainting fits; it resolves when the cause is found.
Hypertension, stage 2: 152/94 and 148/92 mmHg today; told of high blood pressure about three years ago and never treatedactiveconfirmed I10S — Synthetic vascular risk factor; no blood pressure from his lifetime is known.
Hyperlipidemia: LDL 158 mg/dL, triglycerides 170 mg/dL, HDL 44 mg/dLactiveconfirmed E78.5S — Synthetic vascular risk factor; no lipid value from his lifetime is known.
Focal epilepsy with a structural vascular cause: focal impaired-awareness seizures with automatisms, one evolving to a bilateral tonic-clonic seizure, arising from a chronic left temporal cortical infarct, with left temporal sharp waves on EEGactiveconfirmed G40.209S — Synthetic modern diagnosis anchored to the documented falling attacks; the ILAE 2017 seizure types and a structural cause are chosen for teaching and make no claim about what he had.
Chronic left posterior temporal cortical infarct, not recognized before the seizures, with moderate small-vessel white matter disease and a non-stenotic left carotid plaque; no residual deficitactiveconfirmed I69.398S — Synthetic modern finding anchored to the retrospective cerebrovascular hypothesis; it makes no claim about his real brain.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure (target below 130/80 mmHg)Every visitCompleted today140/88 mmHg on lisinopril 10 mg; above target
Self-managementHome blood pressure monitoringDaily while treatment is adjustedDeferredMissed: he did not keep the home log asked for at intake during a busy fortnight. No harm judging by today's office reading (down from 152/94 to 140/88 mmHg) and normal potassium and creatinine. Corrective action: a memory cuff that stores readings, set up in the office today, and a member of his staff to remind him; readings reviewed at the next visit
LaboratoryPotassium and creatinine after starting an ACE inhibitorOne to two weeks after starting or changing the doseCompleted todayPotassium 4.5 mmol/L; creatinine 1.02 mg/dL (0.98 at baseline); eGFR 86
Imaging12-lead ECGAt baselineUp to dateSinus rhythm, left ventricular hypertrophy by voltage, normal intervals (intake)
ImagingAmbulatory rhythm monitoring for atrial fibrillationAt least 30 days within six months of the eventOrdered14-day patch: sinus rhythm throughout. A second monitor for four more weeks fitted today
ImagingBrain MRI and EEGAt diagnosisCompleted todayMRI: chronic left posterior temporal cortical infarct, moderate white matter changes, no acute infarct or other lesion. EEG: left temporal sharp waves
ImagingVascular imaging and echocardiogramAt diagnosis of an ischemic infarctCompleted todayCTA: left carotid plaque under 30 percent, no intracranial stenosis. Echo: no thrombus or shunt, ejection fraction 60 percent
LaboratoryLipid panel after starting a statin4 to 12 weeks after startingDueAtorvastatin 80 mg started today; panel at the ten-week visit
LaboratoryDiabetes screenAt baselineUp to dateHbA1c 5.6 percent at intake
Medication safetyAntithrombotic adherence and bleedingEvery visitCompleted todayAspirin 81 mg started today; dual antiplatelet therapy is for a recent minor stroke or high-risk TIA, not an old infarct
Medication safetyAntiseizure medicine: seizures, adherence, and side effectsEvery visitCompleted todayLevetiracetam 500 mg twice daily started today, with written teaching
SurveyDepression screen (PHQ-9)At the first visit after the event, then periodicallyUp to date3 at intake; repeat at four weeks on levetiracetam
SurveyCognitive screen (MoCA)In the first year after a strokeDueAt the next visit
ExaminationSleep apnea evaluationConsider after any strokeOrderedSTOP-Bang 3; home sleep apnea test ordered
ExaminationFall riskEvery visitCompleted todayNo fall apart from the seizure; seizure precautions cover the risk
ExaminationWeight and BMIEvery visitCompleted today75.8 kg; BMI 22.9
Self-managementTobacco, alcohol, physical activity, and dietEvery visitCompleted todayNever smoker; little alcohol; Mediterranean-style diet with less salt agreed; walking daily
Self-managementSeizure safety and drivingEvery visitCompleted todayNot driving; no swimming or riding alone; showers only; seizure action plan given to his staff
ReferralNeurology consultationAt presentationCompleted todaySeen today; diagnosis and treatment agreed

Goal progress:

Guideline basis: Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015); Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology (2017); ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology (2017); ILAE official report: a practical clinical definition of epilepsy (2014); Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018); 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (2017); 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); CMID: Clinical Monitoring Intelligence Database, stroke and transient ischemic attack, hypertension, and hyperlipidemia monographs (2026)

Follow-up: Four-week chronic-care visit with the monitor results, home blood pressure readings, PHQ-9, and MoCA. Next scheduled visit 2026-09-15: four-week review of levetiracetam, blood pressure, the second rhythm monitor, mood, and cognition. [S]